Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Lancman

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|December 11, 2024
Recommendations for the effective use of T-cell-redirecting therapies: a Canadian consensus statementGuido Lancman, Kevin Song, Darrell White, et al.
Blood Cancer Discovery|October 18, 2021
Bispecific Antibodies in Multiple Myeloma: Present and FutureGuido Lancman, Dahniel L Sastow, Hearn J Cho, et al.
American Journal of Hematology|October 6, 2022
Trial designs and endpoints for immune therapies in multiple myelomaGuido Lancman, Erin Moshier, Hearn Jay Cho, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 15, 2022
Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML PatientsJessica Caro, Rafael Madero-Marroquin, Nicole Zubizarreta, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple MyelomaGuido Lancman, Katleen Lozada, Nida Athar, et al.
Haematologica|April 23, 2026
Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumabGuido Lancman, Dahniel Sastow, Minira Aslanova, et al.
Ejhaem|May 12, 2025
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q AbnormalitiesAshish Patel, Esther Masih-Khan, Adam Smith, et al.
European Journal of Haematology|January 15, 2026
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis-Requiring Severe Renal ImpairmentRintu Sharma, Eshetu G Atenafu, Esther Masih-Khan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 5, 2026
Medication-related osteonecrosis of the jaw: incidence and risk factors in multiple myeloma patients undergoing pre-autologous stem cell transplant dental extractionsJi-Eun Deanna Son, Joo Wan James Kim, Sung-Ha Son, et al.
Blood Cancer Discovery|March 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed Refractory Multiple MyelomaRintu Sharma, Andree-Anne Pelland, Katherine Lajkosz, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|December 11, 2024
Recommendations for the effective use of T-cell-redirecting therapies: a Canadian consensus statementGuido Lancman, Kevin Song, Darrell White, et al.
Blood Cancer Discovery|October 18, 2021
Bispecific Antibodies in Multiple Myeloma: Present and FutureGuido Lancman, Dahniel L Sastow, Hearn J Cho, et al.
American Journal of Hematology|October 6, 2022
Trial designs and endpoints for immune therapies in multiple myelomaGuido Lancman, Erin Moshier, Hearn Jay Cho, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 15, 2022
Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML PatientsJessica Caro, Rafael Madero-Marroquin, Nicole Zubizarreta, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple MyelomaGuido Lancman, Katleen Lozada, Nida Athar, et al.
Haematologica|April 23, 2026
Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumabGuido Lancman, Dahniel Sastow, Minira Aslanova, et al.
Ejhaem|May 12, 2025
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q AbnormalitiesAshish Patel, Esther Masih-Khan, Adam Smith, et al.
European Journal of Haematology|January 15, 2026
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis-Requiring Severe Renal ImpairmentRintu Sharma, Eshetu G Atenafu, Esther Masih-Khan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 5, 2026
Medication-related osteonecrosis of the jaw: incidence and risk factors in multiple myeloma patients undergoing pre-autologous stem cell transplant dental extractionsJi-Eun Deanna Son, Joo Wan James Kim, Sung-Ha Son, et al.
Blood Cancer Discovery|March 11, 2026
Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed Refractory Multiple MyelomaRintu Sharma, Andree-Anne Pelland, Katherine Lajkosz, et al.
Pageof 4